These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10226398)

  • 41. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy.
    Hoff CM
    Acta Oncol; 2012 Apr; 51(4):419-32. PubMed ID: 22313317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The end of the hypoxic EPOch.
    Aguilera TA; Giaccia AJ
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):895-7. PubMed ID: 25832683
    [No Abstract]   [Full Text] [Related]  

  • 43. Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.
    Overgaard J; Eriksen JG; Nordsmark M; Alsner J; Horsman MR;
    Lancet Oncol; 2005 Oct; 6(10):757-64. PubMed ID: 16198981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiosensitizers in the treatment of squamous cell carcinoma of the head and neck.
    Dische S
    Clin Otolaryngol Allied Sci; 1977 Nov; 2(4):403-9. PubMed ID: 340084
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical experiences with the radiation sensitizer MTDQ (Sensorad) in advanced malignancies of the head and neck region and in uterine cancer].
    Kovács G; Németh G; Bär-Pollák Z
    Strahlentherapie; 1984 Oct; 160(10):590-3. PubMed ID: 6388048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.
    Rischin D; Fisher R; Peters L; Corry J; Hicks R
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S61-3. PubMed ID: 17848298
    [No Abstract]   [Full Text] [Related]  

  • 47. A preliminary clinical study in the use of misonidazole in cancer of the head and neck.
    Sealy R
    Br J Cancer Suppl; 1978 Jun; 3():314-7. PubMed ID: 277253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NIMRAD - a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer.
    Thomson D; Yang H; Baines H; Miles E; Bolton S; West C; Slevin N
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):344-7. PubMed ID: 24685344
    [No Abstract]   [Full Text] [Related]  

  • 49. Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.
    Bakowski MT; Macdonald E; Mould RF; Cawte P; Sloggem J; Barrett A; Dalley V; Newton KA; Westbury G; James SE; Hellmann K
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):115-9. PubMed ID: 344287
    [No Abstract]   [Full Text] [Related]  

  • 50. Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air.
    Morse RT; Mell LK
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):783-785. PubMed ID: 38851276
    [No Abstract]   [Full Text] [Related]  

  • 51. An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers.
    Huilgol NG; Chatterjee N; Mehta AR
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1121-4. PubMed ID: 8600096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Photoactivation mechanism of hyaluronidase by chlorpromazine.
    Matsumoto H; Kakegawa H; Shigehara N; Miyataka H; Mitsuo N; Satoh T; Irie T; Uekama K
    Photodermatol; 1987 Oct; 4(5):240-5. PubMed ID: 3697347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of the RTOG recursive partitioning classification for head and neck tumors.
    Cooper JS; Berkey B; Marcial V; Fu KK; Lee DJ
    Head Neck; 2001 Aug; 23(8):669-77. PubMed ID: 11443750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of hypoxic radiosensitizers on the survival and morphology of wild type cell colonies and radiosensitive mutants of Micrococcus radiodurans].
    Groshev VV; Kudriashchova NIu
    Radiobiologiia; 1982; 22(4):536-8. PubMed ID: 7146343
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical science and patient care: lessons from cooperative randomized clinical trials.
    Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):273-4. PubMed ID: 9308927
    [No Abstract]   [Full Text] [Related]  

  • 56. Lonidamine and radiotherapy in head and neck cancers. A pilot study.
    Magno L; Terraneo F; Ciottoli GB
    Oncology; 1984; 41 Suppl 1():113-5. PubMed ID: 6717889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting hypoxia in head and neck cancer.
    Peters LJ
    Acta Oncol; 2001; 40(8):937-40. PubMed ID: 11845958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From laboratory to clinic.
    Dische S; Saunders MI
    BJR Suppl; 1992; 24():179-82. PubMed ID: 1290696
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical use of radiation sensitizing agents.
    Goffinet DR; Bagshaw MA
    Cancer Treat Rev; 1974 Mar; 1(1):15-26. PubMed ID: 4143475
    [No Abstract]   [Full Text] [Related]  

  • 60. Sensitizers of photoradiation and ionizing radiation in the management of head and neck cancer.
    Lebovics RS; DeLaney TF
    Med Clin North Am; 1993 May; 77(3):583-96. PubMed ID: 8492611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.